期刊文献+

中国大陆地区接合菌病流行现状的回顾性分析 被引量:4

Epidemiology of zygomycosis in China's Mainland
下载PDF
导出
摘要 目的了解中国大陆地区近30 a接合菌病流行情况及诊治现状。方法通过CNKI和Pubmed数据库搜索1976年来中国大陆地区接合菌病相关文献,进行数据分析和总结。结果病例报告206篇,共428例患者。感染类型以胃溃疡基础上合并胃肠毛霉菌病为主,其他常见感染类型为肺部、鼻眶脑和皮肤软组织。继发于糖尿病、消化道溃疡、外伤手术烧伤和其他无基础疾病患者多见。病原学诊断主要依赖镜检、培养和病理,仅35株菌鉴定至种的水平,其中6例进行分子生物学鉴定。单独系统抗真菌药物治疗为主,体外药敏试验少,两性霉素B和两性霉素B脂质体为首选用药。428例患者中共死亡126例,占发病总人数的29.43%;其中以全身播散型感染死亡率最高,占此型感染人数的83.34%。结论中国大陆地区接合菌病感染率有上升趋势。感染类型以胃溃疡基础上合并胃肠毛霉菌病为主。应该提高形态学诊断水平,并积极开展分子鉴定,同时有条件情况下应进行菌种的体外药物敏感性检测,为临床提供更为准确的参考信息。 Objective To understand the epidemiology of zygomycosis and the status of diagnosis and treatment in China's Mainland. Methods Literature from 1976 to 2010 were collected by CNKI and Pubmed and statistically analyzed. Results A total of 206 cases and 428 patients were included in our study. The most common infections of gastrointestinal, pulmonary, sinus and cutaneous sites were often secondary to diabetes, gastrointestinal ulceration, burns, surgery, trauma, or no underlying conditions. Etiology diagnosis depended on direct microscopy, cuhure and pathology, and only 6 cases identified by molecular biology. The antifungal therapy was the main treatment and amphotericin B was the first choice in most cases. The mortality was 29.43% (126/428). Conclusions Zygomycosis in mailand China had emerged as an increasingly important fungal infection which was in concordance with the world. Gastrointestinal tract was the most popular involvement. Morphological and molecular biological identification are important for accurate and prompt diagnosis. In vitro susceptibility test is helpful for clinical treatment.
出处 《中国真菌学杂志》 CSCD 2013年第3期163-168,共6页 Chinese Journal of Mycology
关键词 接合菌病 菌种鉴定 诊断 治疗 zygomycosis species identification diagnosis treatment
  • 相关文献

参考文献40

  • 1Bitar D, Van Cauteren D, Lantemier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997 -2006 [J]. Emerg Infect Dis, 2009,15(9) :1395-1401.
  • 2Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplantassociated infection Surveillance Network (TRANSNET) database[J]. Clin Infect Dis, 2010, 50(8) : 1091-1100.
  • 3Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) [J]. Clin Infect Dis, 2010, 50 (8) : 1101-1111.
  • 4Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases [J]. Clin Infect Dis, 2005,41 (5) :634-653.
  • 5Chayakulkeeree M, Perfect JR, Perfect JR. Zygomycosis: the re-emerging fungal infection [J]. Eur J Clin Microbiol Infect Dis, 2006, 25(4): 215-229.
  • 6Roilides E, Zaoutis TE, Katragkou A, et al. Zygomycosis in neonates: an uncommon but life-threatening infection [J]. Am J Perinatol, 2009, 26 (8) : 565 -573.
  • 7Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stemcell transplants[J]. N Engl J Med, 2004, 350(9) :950-952.
  • 8Ribes JA, Vanover-Sams CL, Baker OJ. Zygomycetes in human disease [J]. Clin Microb Rev, 2000,13(2): 236-301.
  • 9Spellberg B, Walsh TJ, Kontoyiannis DP, et al. Recent advances in the management of mucormycosis: from bench to bedside[J]. Clin Infect Dis, 2009, 48(12): 1743-1751.
  • 10Paultauf A. Mycosis mucorina [J]. Arch Path Anat, 1885, 102 :543.

二级参考文献25

  • 1Ribes JA, Vanover-Sams CL, Backer DJ. Zygomycetes in human disease. Clin Microbiol Rev, 2000, 13 : 236-301.
  • 2Sorensen J, Becker M, Porto L, et al. Rhinocerebral zygomycosis in a young girl undergoing allogeneic stem cell transplantation for severe aplastic anaemia. Mycoses, 2006, 49 Suppl 1: 31-36.
  • 3Ritz N, Ammann RA, Aebischer CC, et al. Failure of voficonazole to cure disseminated zygomycosis in an immunocompromised child. Eur J Pediatr, 2005, 164: 231-235.
  • 4Horre R, Jovanie B, Herff S, et al. Wound infection due to Absidia corymbifera and Candida albicans with fatal outcome. Med Mycol, 2004, 42 : 373-378.
  • 5Mohammed S, Sahoo TP, Jayshree RS, et al. Sino-oral zygomycosis due to Absidia corymbifera in a patient with acute leukemia. Med Mycol, 2004, 42: 475-478.
  • 6Cloughley R, Kelehan J, Corbett-Feeney G, et al. Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia. J Clin Microbiol, 2002, 40: 725-727.
  • 7Paterson PJ, Marshall SR, Shaw B, et al. Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation. Bone Marrow Transplant, 2000, 26: 701-703.
  • 8Ruiz P, Peita-Monje A, Tomas-Jimenez C, et al. Septic arthritis due to Absidia corymbifera in a patient with HIV-1 infection. Infection, 2008, 36: 279-281.
  • 9Halweg H, Dyner E, Zagdanska J, et al. Pulmonary mucormycosis caused by Absidia coerulea in a patient with lung cancer. Pneumonol Pol, 1988, 56: 329-335.
  • 10Sun QN, Fothergill AW, McCarthy DI, et al. In vitro activities of posaconazole, itraconazole, voriconazole, amphoterin B and fluconazole against clinical isolates of zygomycetes. Antimicrob Agents Chemother, 2002, 46 : 1581-1582.

共引文献12

同被引文献40

  • 1Xi L, Lu C, Sun J, et al. Chromoblastomycosis caused by a meris- tematic mutant of Fonsecaea monophora [J]. Med Mycol, 2009, 47 ( 1 ): 77-80.
  • 2de Azevedo CM, Gomes RR, Vicente VA, et al. Fonseeaea pugnacius, a novel agent of disseminated chromoblastomycosis [J]. J Clin Microbiol, 2015, 53(8): 82674-82685.
  • 3Najafzadeh MJ, Sun J, Vicente VA, et al. Molecular epidemiology of Fonseeaea species [ J]. Emerg Infect Dis, 2011, 17 ( 3 ): 464-469.
  • 4Kenyon C, Bonorchis K, Corcoran C, et al. A dimorphic fungus causing disseminated infection in South Africa [J ]. N Engl J Med, 2013, 369( 15): 1416-1424.
  • 5Schwartz IS, Govender NP, Corcoran C, et al. Clinical charac- teristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series [J/OL]. Clin Infect Dis, 2015, pii: civ439 [2015-07-21]. http://cid.oxfordjoumals.org/ content/early/2015/06/19/cid.eiv439.1ong. [published online ahead of print Jun 9, 2015].
  • 6Feng P, Yin S, Zhu G, et al. Disseminated infection caused by Emmonsia pasteuana in a renal transplant recipient [J/OL]. J Dermatol, 2015 [2015-07-21] 10.1111/1346-8138.12975/fu11. Jun 24. 20157 http://onlinelibrary.wiley.com/doi/ [published online ahead of print.
  • 7Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, et al. Global epidemiology of sporotrichosis[J]. Med Mycol, 2015, 53( 1 ):3-14.
  • 8Kwok HK, Chan JW, Li IW, et al. Coccidioidomycosis as a rare cause of pneumonia in non-endemic areas: a short exposure history should not be ignored[J]. Respirology, 2009, 14(4): 617-620.
  • 9Geiser DM, Aoki T, Bacon CW, et al. One fungus, one name: defining the genus Fusadum in a scientifically robust way that pre- serves longstanding use [ J]. Phytopathology, 2013, 103 (5): 400-408.
  • 10Schoch CL, Seifert KA, Huhndorf S, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi[J]. Proc Natl Acad Sci U S A, 2012, 109 ( 16 ): 6241-6246.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部